Comment
doi: 10.1136/gutjnl-2018-317426.
Epub 2018 Sep 18.
Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis
Affiliations
- PMID: 30228218
- DOI: 10.1136/gutjnl-2018-317426
Item in Clipboard
Comment
Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis
Gut.
2019 Oct.
No abstract available
Keywords: bile acid; clinical trials; primary biliary cirrhosis.
Conflict of interest statement
Competing interests: CC reports receiving consulting fees from Intercept and Inventiva, grant support from Arrow and Intercept, and fees for teaching from GlaxoSmithKline. AEK reports receiving consulting fees from GlaxoSmithKline and Intercept, and fees for teaching from Falk and Intercept. OC reports receiving grant support from Aptalis, fees for teaching from Mayoly Spindler, consulting fees from Genfit, and fees for teaching and consulting fees from Intercept. RP reports receiving consulting fees from Intercept.
Comment on
-
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28. Gut. 2018. PMID: 29593060 Free PMC article.
Similar articles
-
Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.Trials. 2017 May 23;18(1):230. doi: 10.1186/s13063-017-1966-8. Trials. 2017. PMID: 28535810 Free PMC article. Clinical Trial.
-
[Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial].Internist (Berl). 2018 Dec;59(12):1344-1346. doi: 10.1007/s00108-018-0515-1. Internist (Berl). 2018. PMID: 30357433 German. No abstract available.
-
Bezafibrate in Primary Biliary Cholangitis.N Engl J Med. 2018 Sep 6;379(10):985. doi: 10.1056/NEJMc1809061. N Engl J Med. 2018. PMID: 30184460 No abstract available.
-
Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.J Clin Gastroenterol. 2023 Feb 1;57(2):143-152. doi: 10.1097/MCG.0000000000001797. J Clin Gastroenterol. 2023. PMID: 36598806
-
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?Aliment Pharmacol Ther. 2003 Jan;17(1):17-27. doi: 10.1046/j.1365-2036.2003.01381.x. Aliment Pharmacol Ther. 2003. PMID: 12492729 Review.
Cited by
-
Treatment of Pruritus Secondary to Liver Disease.Curr Gastroenterol Rep. 2019 Jul 31;21(9):48. doi: 10.1007/s11894-019-0713-6. Curr Gastroenterol Rep. 2019. PMID: 31367993 Review.
-
New treatments/targets for primary biliary cholangitis.JHEP Rep. 2019 Aug 9;1(3):203-213. doi: 10.1016/j.jhepr.2019.05.005. eCollection 2019 Sep. JHEP Rep. 2019. PMID: 32039371 Free PMC article. Review.
-
Cholestasis-Associated Pruritus and Its Pruritogens.Front Med (Lausanne). 2021 Mar 9;8:639674. doi: 10.3389/fmed.2021.639674. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33791327 Free PMC article. Review.
-
Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.Front Immunol. 2022 Jul 8;13:940688. doi: 10.3389/fimmu.2022.940688. eCollection 2022. Front Immunol. 2022. PMID: 35880178 Free PMC article. Review.
-
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.Hepatology. 2024 Jul 1;80(1):27-37. doi: 10.1097/HEP.0000000000000728. Epub 2023 Dec 20. Hepatology. 2024. PMID: 38117036 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
